Dow University of Health Sciences attained a milestone by preparing intravenous immunoglobulin (IVIG) with plasma obtained from recovered patients of Corona Virus through which affected sufferers can be treated.
As per Dow research team the treatment is safe, low risk and highly effective. Immunoglobulin is prepared after separation of antibodies found in the blood of recovered patient from the corona. The method is a type of passive immunization but uses purified antibodies rather than the whole plasma.
The team first isolated the SARS-COV2 virus for genome sequencing, then discovered human genes resisting the virus, and now has isolated and purified the antibodies composed of immunoglobulin’s fraction of the recovered patients’ plasma.